Lymphoma

What did the SWOG S1106 trial determine when comparing R-HyperCVAD-R-MA vs BR in newly diagnosed MCL ?
5-yr analysis showed similar efficacy but higher toxicity with Hyper-CVAD /R-MA

en_USEnglish